2022
DOI: 10.1007/s10840-022-01192-2
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac resynchronization therapy in non-ischemic cardiomyopathy: a comparative non-randomized study of His Bundle pacing versus biventricular pacing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 14 publications
0
8
0
Order By: Relevance
“…The systematic search identified 37 eligible publications, 4–8,18–49 including 20 comparative studies—among which four were randomized controlled trials—and 17 single‐arm investigations reporting outcomes in patients undergoing CSP for CRT (details shown in Figure 1). The comparative studies enabled network meta‐analyses of the three interventions—His‐CRT, LBB‐CRT, and BiV‐CRT.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The systematic search identified 37 eligible publications, 4–8,18–49 including 20 comparative studies—among which four were randomized controlled trials—and 17 single‐arm investigations reporting outcomes in patients undergoing CSP for CRT (details shown in Figure 1). The comparative studies enabled network meta‐analyses of the three interventions—His‐CRT, LBB‐CRT, and BiV‐CRT.…”
Section: Resultsmentioning
confidence: 99%
“…The incidence of death and hospitalization were reported, and compared between CSP-CRT and BiV-CRT in 15 studies 4,5,7,8,21,22,27,31,[37][38][39][42][43][44]49 and 12 studies, 4,5,7,21,27,31,[37][38][39]42,44,49 respectively. The relative risk of death was 0.75 (95% CI: [0.61-0.91]; p = .008; I 2 = 0%; Supporting Infomation: Figure S24).…”
Section: Clinical Responsementioning
confidence: 99%
“…A total of five confounding factors were screened, including study design (multi-center and single-center), CSP sample size (>20 and ≤20), male proportion (>50% and ≤50%), CSP types (LBBaP and HBP), and follow-up (≥12 months and <12 months). 2019; Guo et al, 2020;Li et al, 2020;Wang et al, 2020;Liu et al, 2021a;Vinther et al, 2021;Wu et al, 2021;Hua et al, 2022a;Chen et al, 2022;Moriña-Vázquez et al, 2022;Rademakers et al, 2022;Vijayaraman et al, 2022;Wang et al, 2022) the flowchart of study selection is displayed in Figure 1. The baseline characteristics of the eligible studies were presented in Table 1.…”
Section: Discussionmentioning
confidence: 99%
“…The baseline characteristics of the eligible studies were presented in Table 1. Four of fifteen eligible studies were randomized controlled studies (Lustgarten et al, 2015;Upadhyay et al, 2019b;Vinther et al, 2021;Wang et al, 2022), and the literature quality was evaluated with the Cochrane's Risk of Bias Tool (Supplementary Figure S1); meanwhile, the remaining eleven non-randomized studies (Vijayaraman et al, 2019;Guo et al, 2020;Li et al, 2020;Wang et al, 2020;Liu et al, 2021a;Wu et al, 2021;Hua et al, 2022a;Chen et al, 2022;Moriña-Vázquez et al, 2022;Rademakers et al, 2022;Vijayaraman et al, 2022) were evaluated with the Newcastle-Ottawa Scale (NOS) (Supplementary Table S1). The quality of all the studies were good.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation